The IperionX Ltd (ASX: IPX) share price is in focus after the company announced successful validation of its GenX™ continuous titanium production platform, highlighting major advances in throughput and reductions in unit costs.
Image source: Getty Images
What did IperionX report?
- GenX™ system achieved six times higher throughput compared to batch HAMR™ processing, producing over 500 kg of titanium powder.
- Power consumption dropped by more than 75% versus batch processing for each kilogram of titanium powder produced.
- Input use efficiency improved: over 45% less magnesium and more than 60% less hydrogen needed per kilogram.
- All valid product samples met strict ASTM oxygen benchmarks for titanium powder quality.
- Ongoing optimisation and engineering work are planned for industrial-scale production in Virginia.
What else do investors need to know?
GenX™ continuous processing marks a shift away from traditional batch-based titanium production, potentially reducing costs, processing time, and equipment use. The positive test results came from four production runs spanning 41 hours, averaging 12 kg per hour output.
IperionX's process improvements could open more applications for titanium by making large-scale production more viable. The company believes lower reagent and power usage, along with better equipment utilisation, can materially decrease capital and labour costs per tonne.
The next phase involves integrating GenX™ into a complete titanium powder production line and advancing plans for the first industrial-scale GenX™ facility, supported by a recent US$99 million U.S. Army contract.
What did IperionX management say?
CEO and Managing Director Taso Arima said:
Achieving continuous primary titanium production has long been the ultimate aspiration for the titanium industry. IperionX's GenX™ process is a continuous titanium production platform that is more efficient to operate and easier to scale. These first results exceeded our expectations: more than 500 kilograms of recycled titanium powder processed across four separate runs, with every sample meeting its relevant oxygen specification. Substantially lower magnesium, hydrogen and power consumption at steady state, together with processing throughput increasing by six times, give us a strong basis for industrial development. Our next step is the engineering and economic evaluation of the first industrial-scale GenX™ production line. We aim to establish a scalable platform for expansion that lowers production costs and brings titanium within reach of a broader range of applications.
What's next for IperionX?
IperionX will continue to optimise the GenX™ furnace throughout Q4 2026, aiming to integrate the technology into a full-scale titanium powder production line. A technoeconomic evaluation for commercial-scale rollout is underway, targeting further cost and efficiency gains.
With ongoing support from the U.S. Department of Defense, the company's strategy is to develop scalable, continuous titanium production for a wider range of industries, aiming to make titanium more affordable and accessible.
IperionX share price snapshot
Over the past 12 months, IperionX shares have declined 62%, trailing the S&P/ASX 200 Index (ASX: XJO), which has declined 2% over the same period.
